Inconsistent GLP-1 use may blunt weight-loss benefits, Penn study suggests
TL;DR
A Penn study in mice indicates that cycling GLP-1 weight-loss drugs like semaglutide on and off could trigger weight and fat gain and reduce drug effectiveness, highlighting consistency as a key takeaway, though it’s not yet proven in humans and more research is needed on other GLP-1 meds like Zepbound.
Topics:healthhealth-and-fitness#consistency#glp-1#health-and-fitness#semaglutide#therapeutic-resistance#weight-loss
- Penn researchers say inconsistent GLP1 use could reduce effectiveness of weight loss 6abc Philadelphia
- 13 Investigates the benefits and risks from popular weight loss GLP-1 drugs WSET
- Bariatric surgeon talks about the benefits, risks, misconceptions of GLP-1 Agonists News4JAX
- GLP-1 Wars: Winners & Losers Yahoo Finance
- How GLP-1s affect older adults Mayo Clinic Press
Want the full story? Read the original reporting
Read on 6abc Philadelphia